Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$27,315,821
+$18,025,225 QoQ
Shares Held
22,774
+125.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.74%
of 13F equity value
Holder Rank
#752
of 4,604 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Douglass Winthrop Advisors, LLC holds $62,081,020 across 7 Drug Manufacturers - General names. LLY ranks #1 (44.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
22,774 | $27,315,821 | |
| 2 | JNJ |
Johnson & Johnson
|
104,526 | $26,546,468 | |
| 3 | AMGN |
Amgen Inc
|
8,961 | $3,244,957 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
27,548 | $1,587,315 | |
| 5 | NVS |
Novartis AG
|
8,755 | $1,372,083 | |
| 6 | PFE |
Pfizer Inc
|
52,079 | $1,254,062 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
6,018 | $760,314 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,315,821 | 22,774 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $9,290,596 | 10,101 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $10,952,064 | 10,191 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $7,440,776 | 9,752 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $6,702,398 | 8,598 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,292,785 | 8,830 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $6,778,932 | 8,781 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $7,868,033 | 8,881 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $8,135,744 | 8,986 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $7,221,802 | 9,283 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $5,063,826 | 8,687 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $4,504,909 | 8,387 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,952,094 | 8,427 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,900,868 | 8,447 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,035,374 | 8,297 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,682,834 | 8,297 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $2,690,136 | 8,297 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,160,948 | 7,546 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,153,411 | 7,796 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,801,265 | 7,796 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $1,789,337 | 7,796 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $1,457,196 | 7,800 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $836,095 | 4,952 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $732,995 | 4,952 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $788,392 | 4,802 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $694,293 | 5,005 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||